Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TriSalus Life Sciences (TLSIW) Debt Ratio (2022 - 2025)

TriSalus Life Sciences' Debt Ratio history spans 4 years, with the latest figure at 0.94 for Q4 2025.

  • For Q4 2025, Debt Ratio rose 1.52% year-over-year to 0.94; the TTM value through Dec 2025 reached 0.94, up 1.52%, while the annual FY2025 figure was 0.94, 1.52% up from the prior year.
  • Debt Ratio reached 0.94 in Q4 2025 per TLSIW's latest filing, up from 0.9 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 1.11 in Q1 2025 to a low of 0.23 in Q1 2023.
  • Average Debt Ratio over 4 years is 0.79, with a median of 0.8 recorded in 2024.
  • Peak YoY movement for Debt Ratio: fell 20.05% in 2024, then increased 19.01% in 2025.
  • A 4-year view of Debt Ratio shows it stood at 0.72 in 2022, then grew by 14.15% to 0.82 in 2023, then increased by 12.22% to 0.92 in 2024, then grew by 1.52% to 0.94 in 2025.
  • Per Business Quant, the three most recent readings for TLSIW's Debt Ratio are 0.94 (Q4 2025), 0.9 (Q3 2025), and 0.78 (Q2 2025).